EGIDE (ALGID.PA) Fundamental Analysis & Valuation

EPA:ALGID • FR0000072373

Current stock price

1.086 EUR
+0.02 (+1.5%)
Last:

This ALGID.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALGID.PA Profitability Analysis

1.1 Basic Checks

  • ALGID had negative earnings in the past year.
  • ALGID had a positive operating cash flow in the past year.
  • In multiple years ALGID reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALGID reported negative operating cash flow in multiple years.
ALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • ALGID's Return On Assets of -14.07% is on the low side compared to the rest of the industry. ALGID is outperformed by 90.91% of its industry peers.
  • ALGID has a worse Return On Equity (-64.06%) than 90.91% of its industry peers.
Industry RankSector Rank
ROA -14.07%
ROE -64.06%
ROIC N/A
ROA(3y)-13.63%
ROA(5y)-7.33%
ROE(3y)-55.38%
ROE(5y)-31.02%
ROIC(3y)N/A
ROIC(5y)N/A
ALGID.PA Yearly ROA, ROE, ROICALGID.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 62.91%, ALGID belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • ALGID's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALGID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALGID.PA Yearly Profit, Operating, Gross MarginsALGID.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALGID.PA Health Analysis

2.1 Basic Checks

  • ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALGID has been increased compared to 1 year ago.
  • ALGID has a better debt/assets ratio than last year.
ALGID.PA Yearly Shares OutstandingALGID.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALGID.PA Yearly Total Debt VS Total AssetsALGID.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • ALGID has an Altman-Z score of 1.64. This is a bad value and indicates that ALGID is not financially healthy and even has some risk of bankruptcy.
  • ALGID's Altman-Z score of 1.64 is on the low side compared to the rest of the industry. ALGID is outperformed by 70.91% of its industry peers.
  • ALGID has a debt to FCF ratio of 14.31. This is a negative value and a sign of low solvency as ALGID would need 14.31 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 14.31, ALGID is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.98 indicates that ALGID is somewhat dependend on debt financing.
  • ALGID's Debt to Equity ratio of 0.98 is on the low side compared to the rest of the industry. ALGID is outperformed by 83.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 14.31
Altman-Z 1.64
ROIC/WACCN/A
WACC6.99%
ALGID.PA Yearly LT Debt VS Equity VS FCFALGID.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that ALGID should not have too much problems paying its short term obligations.
  • ALGID's Current ratio of 1.57 is in line compared to the rest of the industry. ALGID outperforms 43.64% of its industry peers.
  • ALGID has a Quick Ratio of 1.57. This is a bad value and indicates that ALGID is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALGID has a worse Quick ratio (0.85) than 67.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.85
ALGID.PA Yearly Current Assets VS Current LiabilitesALGID.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALGID.PA Growth Analysis

3.1 Past

  • ALGID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
  • Looking at the last year, ALGID shows a decrease in Revenue. The Revenue has decreased by -8.50% in the last year.
  • Measured over the past years, ALGID shows a very strong growth in Revenue. The Revenue has been growing by 28.35% on average per year.
EPS 1Y (TTM)24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.95%
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y28.35%
Revenue growth 5YN/A
Sales Q2Q%0.97%

3.2 Future

  • The Earnings Per Share is expected to decrease by -25.99% on average over the next years. This is quite bad
  • Based on estimates for the next years, ALGID will show a small growth in Revenue. The Revenue will grow by 0.68% on average per year.
EPS Next Y-41.48%
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue Next Year22.46%
Revenue Next 2Y-1.63%
Revenue Next 3Y0.68%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALGID.PA Yearly Revenue VS EstimatesALGID.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALGID.PA Yearly EPS VS EstimatesALGID.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2022 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALGID.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALGID. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALGID. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGID.PA Price Earnings VS Forward Price EarningsALGID.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • 60.00% of the companies in the same industry are cheaper than ALGID, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 38.3
EV/EBITDA N/A
ALGID.PA Per share dataALGID.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALGID's earnings are expected to decrease with -25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALGID.PA Dividend Analysis

5.1 Amount

  • No dividends for ALGID!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGID.PA Fundamentals: All Metrics, Ratios and Statistics

EGIDE

EPA:ALGID (4/14/2026, 7:00:00 PM)

1.086

+0.02 (+1.5%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-20
Earnings (Next)04-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.30M
Revenue(TTM)30.16M
Net Income(TTM)-3.01M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF 38.3
P/OCF 25.11
P/B 4.53
P/tB 4.53
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.03
FCFY2.61%
OCF(TTM)0.04
OCFY3.98%
SpS1.54
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.07%
ROE -64.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.91%
FCFM 1.84%
ROA(3y)-13.63%
ROA(5y)-7.33%
ROE(3y)-55.38%
ROE(5y)-31.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 14.31
Debt/EBITDA N/A
Cap/Depr 15.76%
Cap/Sales 0.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.85
Altman-Z 1.64
F-Score7
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)34.7%
Cap/Depr(5y)225.04%
Cap/Sales(3y)2%
Cap/Sales(5y)3.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.95%
EPS Next Y-41.48%
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y28.35%
Revenue growth 5YN/A
Sales Q2Q%0.97%
Revenue Next Year22.46%
Revenue Next 2Y-1.63%
Revenue Next 3Y0.68%
Revenue Next 5YN/A
EBIT growth 1Y42.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.97%
OCF growth 3YN/A
OCF growth 5YN/A

EGIDE / ALGID.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

ChartMill assigns a fundamental rating of 2 / 10 to ALGID.PA.


What is the valuation status of EGIDE (ALGID.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to EGIDE (ALGID.PA). This can be considered as Overvalued.


What is the profitability of ALGID stock?

EGIDE (ALGID.PA) has a profitability rating of 2 / 10.


Can you provide the financial health for ALGID stock?

The financial health rating of EGIDE (ALGID.PA) is 1 / 10.